For example, microRNA-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 [21], while miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer [22]. Here, CD44 is linked to prostate carcinoma.